An Open-Label Study Investigating the 5-HT2A Receptor Occupancy of Remlifanserin (ACP-204) With the PET Radioligand [18F]Altanserin in Healthy Male Participants.

Nuplazid (pimavanserin) - Acadia Pharma

remlifanserin (ACP-204) - Acadia Pharma

http://www.ncbi.nlm.nih.gov/pubmed/42677352

Brian Raether; Bryan Dirks; Christine Sandiego; David S Russell; Ethan S Burstein; Eugenii A Rabiner; Mona Darwish; Peter Zhang; Sanjeev Pathak; Xiaoshu Feng

Sep 2, 2026